Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 70.95B P/E 10.69 EPS this Y 1.50% Ern Qtrly Grth -76.60%
Income 4.93B Forward P/E 8.79 EPS next Y 12.60% 50D Avg Chg -1.00%
Sales 30.33B PEG 8,438.20 EPS past 5Y -1.51% 200D Avg Chg -
Dividend 3.00% Price/Book 5.53 EPS next 5Y 0.10% 52W High Chg -16.00%
Recommedations 3.00 Quick Ratio 0.60 Shares Outstanding 4.09B 52W Low Chg 29.00%
Insider Own 2.24% ROA 8.82% Shares Float 3.91B Beta 0.26
Inst Own 44.81% ROE 46.38% Shares Shorted/Prior -/- Price 17.33
Gross Margin 72.34% Profit Margin 16.25% Avg. Volume 2,458 Target Price -
Oper. Margin 20.36% Earnings Date - Volume 363 Change -5.17%
About GSK PLC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

GSK PLC News
08:00 AM GSK PLC Sponsored ADR (GSK) is Attracting Investor Attention: Here is What You Should Know
03/27/24 UPDATE 1-U.S. FDA approves Akebia's anemia drug
03/25/24 With 83% ownership of the shares, GSK plc (LON:GSK) is heavily dominated by institutional owners
03/24/24 12 Best Biotech Penny Stocks to Invest In
03/24/24 Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?
03/19/24 Pfizer to Raise Around $3.5 Billion From Haleon Shares Sale
03/19/24 Pfizer Sells $3.5 Billion of Shares in Haleon
03/18/24 Now That Two Inhaler Makers Are Capping Patient Costs, Will More Follow?
03/18/24 Pfizer Plans to Sell About £2 Billion of Shares in Haleon
03/16/24 Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer
03/14/24 12 Most Profitable Biotech Stocks To Invest In
03/14/24 GSK PLC Sponsored ADR (GSK) Is a Trending Stock: Facts to Know Before Betting on It
03/14/24 The Zacks Analyst Blog Highlights Booz Allen Hamilton, Molson Coors Beverage, Tyson Foods, GlaxoSmithKline and Toyota Motor.
03/13/24 Inflation Remains Sticky in February: 5 Safe Picks
03/13/24 Has GSK PLC Sponsored ADR (GSK) Outpaced Other Medical Stocks This Year?
03/09/24 10 New Alternatives to Antibiotics: Alternative Therapeutic Strategies to Treat Antibiotic-Resistant Pathogens
03/07/24 GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise
03/05/24 13 Best Pharma Dividend Stocks To Buy in 2024
03/01/24 Once a Hot Stock-Market Trend Has a Name, Its Best Days Are Likely Past
02/29/24 Innoviva Inc (INVA) Reports Growth Amidst Challenges in Q4 and Full Year 2023 Financial Results
GLAXF Chatroom

User Image LibsRot Posted - 3 weeks ago

$PFE $JNJ $MRNA $GLAXF https://finance.yahoo.com/news/iterum-itrm-plans-early-submission-125700677.html

User Image dividendinvestorbyeagle Posted - 2 months ago

$GLAXF hit 52 week high (Ord GBP0.25/GSK plc) https://www.dividendinvestor.com/dividend-news/?symbol=glaxf http://dlvr.it/T139bZ

User Image risenhoover Posted - 6 months ago

$GLAXF GLAXF / GSK Plc Price Target Updated https://fintel.io/sfo/us/glaxf?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 7 months ago

$GLAXF GLAXF / GSK Plc Price Target Updated https://fintel.io/sfo/us/glaxf?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image STCKPRO Posted - 07/29/23

$GLAXF NEW ARTICLE : Bristol-Myers Squibb's Bright Future Unfolds Beyond Q2 2023 Turmoil https://www.stck.pro/news/GLAXF/57545143/

User Image STCKPRO Posted - 8 months ago

$GLAXF NEW ARTICLE : GSK Rating Upgraded To Buy On New Earning Asset https://www.stck.pro/news/GLAXF/55907855/

User Image STCKPRO Posted - 8 months ago

$GLAXF NEW ARTICLE : Moderna: Potential To Get Second Product To Market https://www.stck.pro/news/GLAXF/55237726/

User Image risenhoover Posted - 9 months ago

$GLAXF GLAXF / GSK Plc Price Target Updated https://fintel.io/sfo/us/glaxf?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 10 months ago

$GLAXF GLAXF / GSK Plc Price Target Updated https://fintel.io/sfo/us/glaxf?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 11 months ago

$GLAXF GLAXF / GlaxoSmithKline plc Price Target Updated https://fintel.io/sfo/us/glaxf?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$GLAXF GLAXF / GlaxoSmithKline plc Price Target Updated https://fintel.io/sfo/us/glaxf?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$GLAXF GLAXF / GlaxoSmithKline plc Price Target Updated https://fintel.io/sfo/us/glaxf?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$GLAXF GLAXF / GlaxoSmithKline plc Price Target Updated https://fintel.io/sfo/us/glaxf?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$GLAXF GLAXF / GlaxoSmithKline plc Price Target Updated https://fintel.io/sfo/us/glaxf?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$GLAXF GLAXF / GlaxoSmithKline plc Price Target Updated https://fintel.io/sfo/us/glaxf?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$GLAXF GLAXF / GlaxoSmithKline plc Price Target Updated https://fintel.io/sfo/us/glaxf?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$GLAXF GLAXF / GlaxoSmithKline plc Price Target Updated https://fintel.io/sfo/us/glaxf?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$GLAXF GLAXF / GlaxoSmithKline plc upgraded by Deutsche https://fintel.io/sfo/us/glaxf?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=upgrade

User Image risenhoover Posted - 1 year ago

$GLAXF GLAXF / GlaxoSmithKline plc Price Target Updated https://fintel.io/sfo/us/glaxf?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$GLAXF GLAXF / GlaxoSmithKline plc Price Target Updated https://fintel.io/sfo/us/glaxf?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$GLAXF GLAXF / GlaxoSmithKline plc Price Target Updated https://fintel.io/sfo/us/glaxf

User Image Alberto1976 Posted - 1 year ago

"Lyell Immunopharma is a US biotechnology developer of innovative therapies for various types of cancer. [...]" $LYEL $IBB $GSK $GLAXF continue reading the story here: https://seekingalpha.com/article/4577083-lyell-immunopharma-stock-likely-continue-bearish-sell?v=1675999822#comment-94447788

User Image STCKPRO Posted - 1 year ago

$GLAXF NEW ARTICLE : Alector: Trading At Cash Despite Late Stage CNS Pipeline https://www.stck.pro/news/GLAXF/41838252

User Image STCKPRO Posted - 1 year ago

$GLAXF NEW ARTICLE : GSK Shows That The COVID-19 Show Is Passing https://www.stck.pro/news/GLAXF/41754677

User Image Seeking_Alpha_ Posted - 1 year ago

$GLAXF $GSK - GSK Shows That The COVID-19 Show Is Passing. https://t.co/3fahqtfkEp #stocks #investing #business

User Image STCKPRO Posted - 01/30/23

$GLAXF NEW ARTICLE : GSK: A Defensive With A Healthy Dividend Yield https://www.stck.pro/news/GLAXF/41661739

User Image InsiderForms Posted - 1 year ago

Aristotle Capital Management LLC,has filed Form 13F for Q3 2022.Opened NEW positions in $GLAXF $GSK/WI $HLN $HLNCF $MRK

User Image STCKPRO Posted - 1 year ago

$GLAXF NEW ARTICLE : GSK: Near-Term Upside https://www.stck.pro/news/GLAXF/37370141

User Image STCKPRO Posted - 1 year ago

$GLAXF NEW ARTICLE : Aurinia: A Commercial Stage Company With Major Headwinds https://www.stck.pro/news/GLAXF/37103050

User Image STCKPRO Posted - 1 year ago

$GLAXF NEW ARTICLE : Third Point Investors - Colgate-Palmolive: Strong Margin, Significant Upside https://www.stck.pro/news/GLAXF/36617643